Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

MTSR

Metsera Inc

Nov 04 • 10:38AM ET

69.95

+9.22 15.18 %

Healthcare • Biotechnology • USA • NASD

Held by: VTI XBI IWM VB VBK VXF SCHA IWO VTWO IWN

Index	RUT	P/E	-	EPS (ttm)	-	Insider Own	54.41%	Shs Outstand	104.89M	Perf Week	33.44%
Market Cap	7.37B	Forward P/E	-	EPS next Y	-3.60	Insider Trans	-0.00%	Shs Float	48.00M	Perf Month	33.24%
Enterprise Value	6.84B	PEG	-	EPS next Q	-0.72	Inst Own	34.49%	Short Float	10.15%	Perf Quarter	109.24%
Income	-	P/S	-	EPS this Y	79.23%	Inst Trans	5.20%	Short Ratio	2.15	Perf Half Y	207.61%
Sales	-	P/B	16.33	EPS next Y	-19.60%	ROA	-	Short Interest	4.87M	Perf YTD	163.96%
Book/sh	4.28	P/C	13.87	EPS next 5Y	32.84%	ROE	-	52W High	66.10 5.82%	Perf Year	-
Cash/sh	5.04	P/FCF	-	EPS past 3/5Y	-1497.55% -	ROIC	-	52W Low	12.30 468.70%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	2.60% 1.26%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-	Oper. Margin	-	ATR (14)	2.51	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	5.26	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	82.29	Recom	2.00
Dividend Gr. 3/5Y	- -	Current Ratio	5.26	EPS Q/Q	-239.61%	SMA20	27.12%	Beta	-	Target Price	57.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	48.00%	Rel Volume	7.80	Prev Close	60.73
Employees	81	LT Debt/Eq	0.00	Earnings	Jul 28 AMC	SMA200	109.02%	Avg Volume	2.26M	Price	69.95
IPO	Jan 31, 2025	Option/Short	Yes / Yes	EPS/Sales Surpr.	-0.29% -	Trades		Volume	3,803,934	Change	15.18%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-30-25	Downgrade	Wells Fargo	Overweight → Equal Weight	$54
Sep-09-25	Initiated	Leerink Partners	Outperform	$77
Jun-20-25	Initiated	Wells Fargo	Overweight	$65
Feb-25-25	Initiated	Guggenheim	Buy	$56
Feb-25-25	Initiated	Evercore ISI	Outperform
Feb-25-25	Initiated	BofA Securities	Buy	$38

Today 10:47AM	Novo Sweetens Its Bid For Metsera, Pledging Up To $10 Billion (Investor's Business Daily) +15.18%
10:38AM	Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer (Associated Press Finance)
10:22AM	Novo, Pfizer Boost Metsera Bids in Obesity Startup Battle (Bloomberg)
09:58AM	Novo Nordisk Sweetens Offer for Metsera (The Wall Street Journal)
09:09AM	Metsera Receives Amended Proposal from Novo Nordisk; Metsera Declares Novo Nordisk Amended Proposal "Superior" (PR Newswire)
07:20AM	Loading…
07:20AM	Pfizer raises and narrows full-year earnings guidance (Investing.com)
Nov-03-25 04:11PM	Pfizer Reports Earnings Tuesday. Management Has Big Questions to Answer. (Barrons.com)
01:23PM	Did Novo Nordisk Just Say "Checkmate" to Pfizer? (Motley Fool)
12:47PM	Metsera Calls Pfizer's Claims 'Nonsense' In Latest Buyout Battle Salvo (Investor's Business Daily)
12:15PM	Pfizer files second lawsuit to block Novo Nordisks $9bn Metsera bid (Financial Times)
12:03PM	Pfizer Aligns With Trump on Drug Pricing In Its Bid for Biotech Metsera (Barrons.com)
11:02AM	Metsera Issues Statement in Response to Litigation (PR Newswire)
09:34AM	Kimberly-Clark to buy Tylenol maker Kenvue, Iren & Microsoft deal (Yahoo Finance Video)
09:19AM	Pfizer Files Antitrust Suit to Block Novo Nordisk Acquisition of Metsera (The Wall Street Journal)
07:44AM	Pfizer hits Novo Nordisk and Metsera with lawsuit amid bidding war (Pharmaceutical Technology)
06:43AM	Loading…
06:43AM	Stocks to Watch Monday: Kenvue, Kimberly-Clark, Berkshire Hathaway (The Wall Street Journal)
04:46AM	Meet the 7% Yield Dividend Stock That Could Soar in 2026 (Motley Fool)
01:35AM	Metsera (MTSR) Jumps 20% as Big Pharma Battle Heats Up Over Takeover (Insider Monkey)
Nov-02-25 05:30AM	Why Pfizer Can Still Prevail in the Obesity Fight With Novo Nordisk (The Wall Street Journal)
Nov-01-25 11:46AM	Pfizer sues Metsera, Novo in effort to enforce buyout deal (BioPharma Dive)
Oct-31-25 06:44PM	Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal (The Wall Street Journal)
06:24PM	Metsera Issues Statement in Response to Litigation (PR Newswire)
05:30PM	Pfizer Sues Novo Nordisk And Metsera To Block The Proposed $6.5 Billion Deal (Investor's Business Daily)
05:28PM	Pfizer sues to stop rival bid for drugmaker Metsera by Denmark's Novo Nordisk (Associated Press Finance)
03:50PM	Pfizer Receives Early Clearance from U.S. Federal Trade Commission for Metsera Acquisition (Business Wire)
12:36PM	Health Care Roundup: Market Talk (The Wall Street Journal)
11:07AM	Pfizer Q3 Earnings Loom: Buy, Sell or Hold PFE Stock Ahead of Results? (Zacks)
10:28AM	Novo Nordisk cuts 9,000 jobs as it looks to new weight-loss drugs (Reuters Videos)
10:03AM	Metsera (MTSR) Soars to All-Time High on Pfizer, Novo Billion-Dollar Bidding War (Insider Monkey)
08:03AM	Massive sales for weight loss drugs spur Eli Lillys Q3 (Pharmaceutical Technology)
05:50AM	Loading…
05:50AM	Bull market not solely driven by AI. M&A is starting to heat up. (MarketWatch)
Oct-30-25 06:53PM	Mizuho's Holtz talks what is behind Novo's bid for Metsera (CNBC TV) +22.06%
04:47PM	These Stocks Moved the Most Today: Meta, Microsoft, Alphabet, FMC, C.H. Robinson Worldwide, Roblox, Metsera, Chipotle, and More (Barrons.com)
04:35PM	Stocks to Watch Thursday Recap: Eli Lilly, Metsera, Navan, Chipotle (The Wall Street Journal)
04:13PM	Novo Nordisk Kicks Off Bloody Battle With Pfizer, Bidding $6.5 Billion On Metsera (Investor's Business Daily)
03:03PM	Novo Nordisk takes on Pfizer in bid for obesity biotech Metsera (Reuters Videos)
02:16PM	Pfizer said to mull suing Novo Nordisk over Metsera bid (Investing.com)
02:11PM	Novo Nordisk Tries to Snatch a Weight-Loss Biotech From Pfizer. There Are Political Risks. (Barrons.com)
02:10PM	These Stocks Are Moving the Most Today: Meta, Microsoft, Alphabet, FMC, C.H. Robinson Worldwide, Roblox, Metsera, Chipotle, and More (Barrons.com)
01:31PM	Bidding war rises over weight loss drug that could prevent Ozempic face (The Telegraph)
01:11PM	Chipotle drags fast casual stocks lower, Meta reports raising $125B (Yahoo Finance Video)
12:52PM	Novo Nordisk Seeks to Outmuscle Pfizer With $9 Billion Bid for Metsera (The Wall Street Journal)
12:27PM	Halper Sadeh LLC Encourages GES, MTSR, TGNA, CYBR Shareholders to Contact the Firm to Discuss Their Rights (PR Newswire)
11:23AM	Novo Nordisk locks horns with Pfizer in late bid for Metsera (Pharmaceutical Technology)
10:41AM	Stocks to Watch Thursday: Eli Lilly, Metsera, Navan, Chipotle (The Wall Street Journal)
10:39AM	Obesity, diabetes treatments fuel Eli Lilly growth and spark bidding war (Associated Press Finance)
10:04AM	Novo, Pfizer Square Off Over Metsera in Obesity-Drug Tussle (Bloomberg)
09:25AM	Novo Nordisk's bid for Metsera, Eli Lilly boosts revenue outlook (Yahoo Finance Video)
09:13AM	Novo Nodrisk stock dips on aggressive odder to buy Metsera, reckless says Pfizer (Investing.com)
08:20AM	Novo Nordisk launches bidding war with Pfizer for obesity drugmaker Metsera (AFP)
07:57AM	Mounjaro Powers Eli Lilly to Bumper Quarter of Earnings (The Wall Street Journal)
07:11AM	Metsera Stock Soars. Novo Nordisk Looks to Outbid Pfizer for the Obesity-Drug Maker. (Barrons.com)
07:07AM	Metsera Receives Unsolicited Proposal from Novo Nordisk (PR Newswire)
06:57AM	Pfizer Addresses Proposal for Metsera (Business Wire)
06:32AM	Pfizer and Roche place $10bn bets on obesity and liver disease therapies as Trump tightens grip on drug pricing and manufacturing (Pharmaceutical Technology)
06:23AM	Novo Nordisk Moves to Outbid Pfizer With Up to $9 Billion Offer for Obesity Drug Developer Metsera (The Wall Street Journal)
Oct-27-25 06:24AM	Google Parent Alphabet Has $754 Million Invested in These 3 Hot Growth Stocks. Here's the 1 Wall Street Likes the Most. (Motley Fool)
Oct-13-25 08:45AM	Where Will Pfizer Be in 5 Years? (Motley Fool)
05:30AM	Why Biotech's Rally Can Last This Time (The Wall Street Journal)
Oct-07-25 09:30AM	Down 50%, Should You Buy the Dip on Pfizer? (Motley Fool)
Oct-06-25 04:59AM	3 Reasons to Buy Pfizer Stock Now (Motley Fool)
Oct-02-25 07:02AM	3 Things You Need to Know if You Buy Pfizer Today (Motley Fool)
Sep-30-25 11:02AM	Metsera Posts Promising Weight-Loss Drug Results. It Could Be a Win for Pfizer. (Barrons.com)
07:50AM	Metsera strengthens case for Pfizer buyout with latest study data (BioPharma Dive)
04:00AM	Pfizer Just Reminded Investors Why You Should Never Count Its Stock Out (Motley Fool)
Sep-29-25 04:01PM	Metsera Reports Positive Phase 2b Results for First- and Best-in-Class Ultra-long Acting GLP-1 RA Candidate MET-097i, Enabling Rapid Transition into Phase 3 (GlobeNewswire)
Sep-28-25 10:58AM	Down 55%, Should You Buy the Dip on Pfizer? (Motley Fool)
Sep-27-25 08:15AM	Is Pfizer Stock a Buy After Its $5 Billion GLP-1 Bet? (Motley Fool)
Sep-26-25 04:33PM	Pfizer is Locking in New Growth Through a New Acquisition (MarketBeat)
08:45AM	Did Pfizer Just Give Investors 7 Billion Reasons to Buy Its Stock? (Motley Fool)
Sep-25-25 09:35AM	Metsera downgraded to Market Perform from Outperform at Leerink (TipRanks)
04:00AM	Can a multibillion-dollar deal put Pfizer in the obesity big leagues? (Pharma Voice)
Sep-23-25 06:55PM	Time to Buy Pfizer (PFE) or Metsera (MTSR) Stock? (Zacks)
02:13PM	Metsera (MTSR) Soars to All-Time High on $7.3-Billion Merger With Pfizer (Insider Monkey)
12:16PM	Can PFE Successfully Return to the Obesity Space With Metsera Buyout? (Zacks)
05:30AM	This Hated Stock Suddenly Looks Like an Obesity Bargain (The Wall Street Journal)
04:35AM	Company News for Sep 23, 2025 (Zacks)
03:47AM	What's Pfizer Getting in Its $7.3 Billion Metsera Buyout? (Motley Fool)
02:41AM	Heard on the Street Tuesday Recap: Even Tylenol Cant Cool This AI Fever (The Wall Street Journal)
Sep-22-25 11:49PM	Asian shares trade mixed after US stocks set more records (Associated Press Finance) +60.80%
09:41PM	Market Movers: Metsera and Apple surge, Kenvue falters on Tylenol troubles (TheStreet)
06:00PM	Podcast: Nasdaq Leads U.S. Stocks to New Records (The Wall Street Journal)
04:20PM	Stocks to Watch Recap: Nvidia, Oracle, Pfizer, Kenvue, Compass (The Wall Street Journal)
04:12PM	These Stocks Moved the Most Today: Oracle, Nvidia, Metsera, Pfizer, Kenvue, Tesla, Anywhere Real Estate, and More (Barrons.com)
02:53PM	These Stocks Are Moving the Most Today: Oracle, Nvidia, Metsera, Pfizer, Kenvue, Tesla, Anywhere Real Estate, and More (Barrons.com)
01:50PM	Stocks to Watch Monday: Nvidia, Oracle, Pfizer, Kenvue, Compass (The Wall Street Journal)
01:28PM	Why Pfizer Stock Just Popped (Motley Fool)
12:51PM	Pfizer Joins Obesity Drug Race With $5B Metsera Purchase (Bloomberg)
12:26PM	Pfizer buys monthly GLP-1RA developer Metsera for $4.9bn (Pharmaceutical Technology)
11:17AM	Pfizer Jumps Back into the Weight-Loss Race With $4.9B Acquisition (Barrons.com)
11:08AM	Pfizer Stock Higher on Multi-Billion Dollar Metsera Buyout (Schaeffer's Research)
10:37AM	Stock Market Today: Dow Up As Apple, Tesla Gain On These Calls; Oracle Pops After Executive Shuffle (Live Coverage) (Investor's Business Daily)
10:37AM	Stock Market Today: Dow Falls As Apple, Tesla Gain On These Calls; Obesity Play Rockets On Pfizer Move (Live Coverage) (Investor's Business Daily)
09:56AM	Pfizer eyes obesity drug market as it seals $4.9bn deal for Metsera (Euronews)
09:41AM	Stocks to Watch Monday: Oracle, Pfizer, Fox, Compass (The Wall Street Journal)
09:31AM	Oracle, Pfizer & Metsera, Kenvue: Trending tickers (Yahoo Finance Video)
09:11AM	Pfizer Claws Deeper Into The Obesity Space With $4.9 Billion Metsera Deal (Investor's Business Daily)
08:57AM	Pfizer Jumps Into Weight-Loss Drug Segment With $7.3 Billion Metsera Deal (Investopedia)
08:54AM	Pfizer to acquire Metsera: Breaking News (Yahoo Finance Video)
08:26AM	5 Things to Know Before the Stock Market Opens (Investopedia)

Metsera, Inc. is a clinical stage biopharmaceutical company, which engages in the development of a next-generation injectable and oral nutrient stimulated hormone, or NuSH, analog peptides to treat obesity, overweight and related conditions. Its product pipeline includes MET-097i, MET-233, and MET-224o. The company was founded by Clive A. Meanwell on June 29, 2022 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
FMR LLC	See Remark 1	Sep 02 '25	Sale	36.00	268	9,648	0	Sep 04 02:58 PM
Burow Kristina	Director	Feb 03 '25	Buy	18.00	2,222,222	39,999,996	18,503,128	Feb 03 07:15 PM
BERNS PAUL L	Director	Feb 03 '25	Buy	18.00	789,998	14,219,964	8,313,680	Feb 03 07:04 PM
ARCH Venture Partners XII, LLC	10% Owner	Feb 03 '25	Buy	18.00	2,222,222	39,999,996	18,503,128	Feb 03 07:01 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MTSR

Metsera Inc

Upgrade your FINVIZ experience